Corporate Culture Has No Place in Academia
By Olof Hallonsten,
Nature News
| 10. 03. 2016
The eyes of the world are on the Karolinska Institute in Stockholm this week for the announcement of the Nobel prize in medicine, but an ugly medical scandal lurks in the background. The case of Paolo Macchiarini involved the deaths of multiple patients and several instances of research fraud, and has exposed the misdeeds of a single professor. But it also demonstrates the risks of academic capitalism: a global trend that turns universities into businesses. In this respect, the story has wider lessons for us all.
As academic capitalism spreads, universities abandon traditional meritocratic and collegial governance to hunt money, prestige and a stronger brand. Here in Sweden, this shift has been especially profound: since the 1980s, the university system has been deregulated, and its core principles gradually replaced by management practices from the corporate world. Government research policy over the past decade has further pushed universities to centralize their strategic management and increase their international visibility. Major strategic funding programmes included one to recruit international star scientists.
An investigation into the Macchiarini scandal, led by a former president of...
Related Articles
By Marisa Flook , BioNews | 06.29.2026
An anti-ageing gene therapy not approved by the US Food and Drug Administration (FDA) is set to be offered by an American company at overseas clinics outside of US jurisdiction.
The treatment, developed by Minicircle from Austin, Texas, uses a...
By Ed Pilkington, The Guardian | 06.12.2026
Desperate US parents paying up to $20,000 a session for a procedure scientists say could be bogus
Autistic children as young as 18 months old are being injected with human stem cells derived from umbilical cords in unapproved, unproven and...
By Tobi Thomas, The Guardian | 06.10.2026
The UK’s stem cell transplant system is potentially putting the lives of blood cancer patients at risk as a result of inadequate infrastructure and a lack of long-term planning, a parliamentary report has found.
A hematopoietic stem cell transplant, often...
By Virginia Heffernan, The New Republic | 05.29.2026
Here and there, it’s been a good month for humanity—or “magnificas humanitas,” as Pope Leo XIV calls us poor featherless bipeds.
On May 25, the pope published his encyclical letter “on safeguarding the human person in the time of artificial...